4.7 Review

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 132, Issue -, Pages 235-251

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2018.06.011

Keywords

3D printing; Tissue model; Drug screening; Disease model; In vitro culture; Tissue engineering; Biomaterials

Funding

  1. California Institute for Regenerative Medicine [RT3-07899]
  2. National Institutes of Health [R01EB021857, R21HD090662]
  3. National Science Foundation [CMMI-1547005, CMM1-1644967]

Ask authors/readers for more resources

3D bioprinting is emerging as a promising technology for fabricating complex tissue constructs with tailored biological components and mechanical properties. Recent advances have enabled scientists to precisely position materials and cells to build functional tissue models for in vitro drug screening and disease modeling. This review presents state-of-the-art 3D bioprinting techniques and discusses the choice of cell source and biomaterials for building functional tissue models that can be used for personalized drug screening and disease modeling. In particular, we focus on 3D-bioprinted liver models, cardiac tissues, vascularized constructs, and cancer models for their promising applications in medical research, drug discovery, toxicology, and other pre-clinical studies. (C) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available